SCHEMBL16558099

SCHEMBL16558099

CCCNc1ccc(N=Nc2ccc(S(=O)(=O)c3ccc(N=Nc4ccc(NCCC)c5ccccc45)cc3)cc2)c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.46
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ MAPT P10636 3/20 0.45
▸ MAPK1 P28482 3/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ POLB P06746 2/20 0.45
▸ LMNA P02545 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ GLO1 Q04760 4/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ CASP6 P55212 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ KLF5 Q13887 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ CA12 O43570 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8275182 0.88 IDO1 (0.46) IDO1MEN1KMT2AMAPTMAPK1
SCHEMBL8439504 0.79 MEN1 (0.48) IDO1MEN1KMT2AMAPTMAPK1
SCHEMBL21580219 0.79 MEN1 (0.48) IDO1MEN1KMT2AMAPTMAPK1
SCHEMBL30133461 0.79 MEN1 (0.48) IDO1MEN1KMT2AMAPTMAPK1
SCHEMBL8814557 0.78 CHEK1 (0.52) IDO1MEN1KMT2AMAPTMAPK1
SCHEMBL11324762 0.78 IDO1 (0.53) IDO1MEN1KMT2AMAPTMAPK1
SCHEMBL10909631 0.78 IDO1 (0.53) IDO1MEN1KMT2AMAPTMAPK1
SCHEMBL11324765 0.78 IDO1 (0.53) IDO1MEN1KMT2AMAPTMAPK1
SCHEMBL11693912 0.76 MEN1 (0.50) IDO1MEN1KMT2AMAPTMAPK1
SCHEMBL11693919 0.76 MEN1 (0.50) IDO1MEN1KMT2AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150072966-A1 METHOD OF PROMOTING WOUND HEALING 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150072966-A1 METHOD OF PROMOTING WOUND HEALING NOS3, NOS1, NOS2 IDO1 625/4885MEN1 3555/4885KMT2A 4829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback